Regenxbio Price Sales Ratio from 2010 to 2024

RGNX Stock  USD 9.58  0.01  0.10%   
Regenxbio Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio will likely drop to 8.26 in 2024. During the period from 2010 to 2024, Regenxbio Price Sales Ratio regression line of annual values had r-squared of  0.46 and arithmetic mean of  42.67. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
8.69911239
Current Value
8.26
Quarterly Volatility
35.26913842
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Regenxbio over the last few years. It is Regenxbio's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Regenxbio Price Sales Ratio Regression Statistics

Arithmetic Mean42.67
Geometric Mean25.82
Coefficient Of Variation82.65
Mean Deviation30.95
Median42.66
Standard Deviation35.27
Sample Variance1,244
Range104
R-Value(0.68)
Mean Square Error721.59
R-Squared0.46
Significance0.01
Slope(5.36)
Total Sum of Squares17,415

Regenxbio Price Sales Ratio History

2024 8.26
2023 8.7
2022 8.68
2021 2.95
2020 10.94
2019 42.66
2018 7.03

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 8.70  8.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.